Daicel Corporation (TYO: 4202)

Market Cap	359.99B
Revenue (ttm)	576.74B
Net Income (ttm)	58.14B
Shares Out	270.16M
EPS (ttm)	209.34
PE Ratio	6.37
Forward PE	6.83
Dividend	60.00 (4.55%)
Ex-Dividend Date	Mar 28, 2025

Volume	387,800
Average Volume	628,420
Open	1,329.00
Previous Close	1,319.50
Day's Range	1,326.00 - 1,340.00
52-Week Range	1,064.00 - 1,640.00
Beta	0.45
RSI	43.01
Earnings Date	Feb 5, 2025

About Daicel

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, s...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1919
• Employees: 11,134
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4202

Financial Performance

In 2023, Daicel's revenue was 558.06 billion, an increase of 3.72% compared to the previous year's 538.03 billion. Earnings were 55.83 billion, an increase of 37.24%.